Indicated preterm births (PTBs) represent nearly 35% of PTBs.
We aim to examine the impact of indication for preterm delivery (maternal, fetal, or obstetric) on immediate neonatal outcomes. Given that previous studies demonstrate an increased rate of morbidities associated with IUGR for preterm delivery, we hypothesize that immediate neonatal outcomes will vary by indication for delivery, specifically that those delivered for fetal or obstetric indications will have a worse prognosis compared with those delivered for other indications.
Materials and Methods
This was a retrospective cohort study of all preterm singletons with an indicated delivery from January 1, 2011, to December 31, 2014. Institutional Review Board approval was obtained from the University of Alabama at Birmingham.
All women delivered 23 to 34 weeks at a single institution from 2011 to 2014. At our institution, maternal-fetal medicine faculty and fellows provide 24-hour coverage of labor and delivery 7 days per week. Trained chart abstractors completed standardized chart abstraction forms using a secure database. Information that was obtained include: maternal demographics, maternal medical and obstetric history, antenatal course, pregnancy outcomes, and primary indications for delivery. In cases where multiple indications were listed, the primary indication for delivery was selected based on physician documentation. Subjects were excluded for delivery prior to 23 weeks, lack of fetal monitoring (or no intent to resuscitate), fetal anomalies, intrauterine fetal demise, spontaneous labor (including preterm premature rupture of membranes) suspected morbidly adherent placenta, maternal cardiac disease, or testing human immunodeficiency virus (HIV) positive.
Women were classified by their primary indication for delivery: maternal (preeclampsia) or fetal/obstetric. A majority of fetal and obstetric indications were nonreassuring fetal status, placental abruption, placenta previa with bleeding, and fetal growth restriction.
The primary neonatal outcome was a composite of neonatal death, cord pH <7 or base excess < À 12, 5-minute Apgar 3, C-reactive protein (CPR) during resuscitation, culture-proven sepsis, grades III to IV intraventricular hemorrhage, and necrotizing enterocolitis. Secondary outcomes included the individual components of the primary outcome. These outcomes were chosen as they are associated with significant risks of neonatal mortality or long-standing neonatal morbidities, including hypoxic ischemic encephalopathy.
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The exposure groups were compared with descriptive and bivariate statistics using Student's t-test for continuous variables and chi-squared test for categorical variables. Potentially confounding variables of the exposure-outcome association were identified in the stratified analyses. Multivariable logistic regression models for the primary and secondary outcomes were then developed to estimate the effect of indication for delivery on immediate neonatal outcomes, using maternal indications as the reference group. Clinically relevant covariates for initial inclusion in multivariable statistical models were selected using results of the stratified analyses, and factors were removed in a backward stepwise fashion, based on significant changes in the exposure adjusted odds ratio (AOR) or significant differences between hierarchical models using the likelihood ratio test. Confounding factors considered included antenatal corticosteroids steroids, gestational age at delivery, maternal body mass index (BMI), race, sex of the neonate, intended mode of delivery, and parity. All analyses were completed using STATA SE, version 13 (College Station, TX).
Results
Of 1,352 identified with a singleton PTB at 23 to 34 weeks, 824 were excluded (703 excluded for spontaneous labor, 65 excluded for fetus with anomalies, 19 excluded for maternal cardiac disease, 17 excluded for lack of fetal monitoring, 9 for suspected morbidly adherent placenta, 5 excluded for rare maternal indications other than preeclampsia, 3 excluded for being tested HIV positive, 2 excluded for outside the gestational age range, and 1 for unclear indication for delivery). Of the 528 women eligible, 395 (74.8%) had a maternal indication as their primary indication for delivery, and 133 (25.2%) had a fetal/obstetric indication (►Fig. 1). For those in the fetal/ obstetric indication category, 99 (74.4%) had nonreassuring fetal status, 12 (9.0%) had placental abruption, 7 (5.3%) had vaginal bleeding, 6 (5.4%) were intrauterine growth restricted (IUGR) with reversal of end-diastolic flow, 5 (4.5%) had IUGR with absent end-diastolic flow, 2 (1.5%) had oligohydramnios, 1 (0.9%) had IUGR with normal umbilical artery Doppler, and 1 (0.9%) had suspected isoimmunization. Of those included with a maternal indication as their primary indication, 395 (100%) had preeclampsia, eclampsia, or HELLP.
Maternal characteristics according to primary indication for delivery are shown in ►Table 1. Exposure groups were not significantly different with regard to maternal age, gestational age at delivery, marital status, race, previous preterm pregnancies diabetes, and renal disease. Women with a maternal indication for delivery were more likely to be nulliparous, have chronic hypertension, and have a higher BMI than the obstetric or fetal groups. Those with a maternal indication were less likely to have had a prior vaginal delivery, smoke, and report alcohol or drug use.
Obstetric characteristics are shown in ►Table 2. Preeclampsia was diagnosed in all of the maternal indication groups but was also diagnosed in more than 35.3% of the fetal/obstetric indication group (p < 0.01). Estimated fetal weight was lowest and the diagnosis of fetal growth restriction was most common in the fetal/obstetric indications group (p < 0.01), as were critically abnormal Doppler in those diagnosed with fetal growth restriction (p < 0.01). Patients in the maternal indications group were most likely to complete a course of antenatal corticosteroids (p < 0.01). Gestational age and birth weight were significantly different between the groups, with the fetal indication group having the earliest gestational age and lowest birth weight.
Neonatal outcomes according to primary indication are displayed in ►Table 3. Infants in the fetal/obstetric indication group had a higher incidence of the neonatal composite outcome compared with the maternal indication groups (p < 0.01). After adjusting for antenatal corticosteroid use, gestational age at delivery and maternal BMI, neonates delivered for fetal/obstetric indications had a significantly higher odds of the composite neonatal outcome compared with those delivered for maternal indications (AOR: 1.9, 95% confidence interval [CI]: 1.14-3.21).
We then examined components of the primary neonatal outcome individually. An increase in the risk of neonatal death in the fetal/obstetric indication group did not remain statistically significant compared with the maternal indication group after adjusting for gestational age at delivery and antenatal corticosteroids. Those delivered for fetal/obstetric indications were at significant increased risk of having an acidemic cord blood gas (AOR: 4.2, 95% CI: 1.89-9.55). The remaining components of the primary outcome (intraventricular hemorrhage, culture-proven sepsis, necrotizing enterocolitis, 5-minute Apgar 3, and CPR in the delivery room) were not significantly increased in the fetal indication or obstetric indication groups compared with those delivered for maternal indications after adjusting for important confounding factors.
Discussion
In this cohort of women undergoing indicated preterm deliveries between 23 and 34 weeks, fetal and obstetric indications for delivery were associated with worsened immediate neonatal outcomes compared with maternal indications.
Medically indicated PTBs have been an increasing area of study in recent years, with several large population-based studies demonstrating that indicated PTB are associated with higher morbidity and mortality risk when compared with spontaneous preterm labor. [4] [5] [6] [7] [18] [19] [20] In a multicenter prospective study with a comparable total sample size, Garite et al found that of all medically indicated preterm deliveries in their population, only suspected IUGR infants had worsened outcomes. 7 Our study findings suggest that infants delivered due to any fetal or obstetric indication may have an increased risk for severe morbidities, not just those that are growth restricted. Prior studies examining neonatal outcomes in preterm deliveries have focused primarily on differences in spontaneous versus medically indicated preterm deliveries as an overarching category. Recent studies have shown, however, that there is a broad spectrum of heterogeneity of clinical subtypes of medically indicated PTB, which are each associated with different risk factors and causal factors. 21 As this variance in underlying causes potentially has a diverse influence on delivery outcomes, those previous studies contrasting outcomes of all medically indicated PTBs to spontaneous births may have drawn overly broad comparisons. Our focus on differences among medically indicated preterm deliveries allows for more detailed counseling of this patient population. Previous studies have mostly used large existing national databases which provide a large sample size to examine rare outcomes. However, due to known underreporting of medical diagnoses and obstetric complications, these databases are limited by misclassification biases. 3, 22, 23 Our study with data collected from medical records by trained abstractors limits misclassification bias; additionally, due to the highrisk nature of this cohort, we maintained the sample size required to examine rare neonatal outcomes. Finally, we Outcomes of Medically Indicated PTBs Differ by Indication Wang et al.
selected as our primary neonatal outcome a composite of significant adverse events that are strongly associated with significant neonatal morbidity and mortality.
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We acknowledge some study limitations. First, although we attempted to control for the known differences between the groups, residual confounding may persist. Furthermore, only preeclampsia was studied as a maternal indication for delivery due to the rarity of other indications. Some patients may have qualified for more than one single indication group; however, to simplify our analysis, we chose to focus on what we determined through the chart extraction process to be the "primary" indication for delivery. While we recognize that multiple indications may exist, we selected the indication listed as the delivering physician as primary. For example, a patient expectantly managed for preeclampsia who was delivered for nonreassuring fetal status would have been classified as obstetric. Stout et al have demonstrated reasonable interobserver agreement with PTB classification. 24 While patients could have been misclassified (biasing our results to the null), the detailed patient-level data available likely enabled us to more accurately classify patients than large birth certificate databases allow. In sum, the indication for medically indicated PTBs appears to have a significant impact on important immediate neonatal outcomes. However, existing evidence-based counseling lacks concise and differentiated strategies for treating various types of medically indicated preterm deliveries. With personalized medicine at frontier of patient care as providers seek to utilize the increasing breadth of specific diagnostic information to create individualized interventions, the information gathered in this study presents important initial preterm indication-specific data to help refine obstetric counseling. Further research is thus needed to examine the outcomes of different interventions on specific indications to allow physicians to tailor counseling to the indication for 
